Riskpilot← Back to searchSign inGet full accessNOVACARE ApS
APSActiveCVR 17478435Strandvejen 100Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19931 employees
Revenue 2024
DKK 122K
-186% vs 2023
EBITDA margin
100.0%
+186% vs 2023
Equity ratio
27.4%
Financial strength
Net profit 2024
DKK 13K
+108% vs 2023
| Revenue | DKK 122K | -186% |
| EBITDA | DKK 122K | +186% |
| Net profit | DKK 13K | +108% |
| Total assets | DKK 2M | -29% |
| Equity | DKK 539K | +3% |
| Employees | 1 | — |
Legal name
NOVACARE ApS
CVR number
17478435
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. december 1993
Share capital
DKK 300.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er handel og industri.
Address
Strandvejen 100
Phone
+4533330835
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.229 | 449 | 1.766 | 2.154 | 1.637 | 1.090 | 1.494 | 1.263 | 1.432 | 272 | 267 | -143 | 122 |
| Staff expenses | -627 | -609 | -747 | -1.562 | -1.408 | -1.145 | -1.182 | -1.037 | -935 | -544 | -6 | -0 | -0 |
| EBITDA | 602 | -160 | 880 | 592 | 229 | -55 | 313 | 226 | 498 | -272 | 262 | -143 | 122 |
| Depreciation & amort. | -77 | -57 | -55 | -36 | -47 | -134 | -134 | -131 | -127 | -72 | -3 | -3 | -74 |
| EBIT | 525 | -217 | 824 | 557 | 182 | -189 | 179 | 94 | 371 | -344 | 258 | -146 | 48 |
| Net financials | -76 | -75 | -137 | -74 | -91 | -147 | -103 | -114 | -143 | -151 | -122 | -19 | -35 |
| Profit before tax | 449 | -157 | 687 | 482 | 91 | -336 | 76 | -19 | 228 | -495 | 137 | -165 | 13 |
| Tax | 117 | 67 | 170 | 113 | 20 | -66 | 13 | -3 | 52 | -151 | 30 | -0 | -0 |
| Net profit | 332 | -224 | 517 | 370 | 71 | -270 | 63 | -17 | 176 | -344 | 107 | -165 | 13 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.659 | 2.542 | 3.691 | 3.102 | 4.023 | 3.800 | 3.493 | 3.723 | 3.998 | 3.835 | 3.394 | 2.765 | 1.968 |
| Equity | 663 | 439 | 537 | 907 | 977 | 707 | 770 | 753 | 929 | 585 | 691 | 526 | 539 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.995 | 2.103 | 3.154 | 2.181 | 3.012 | 3.093 | 2.723 | 2.970 | 3.040 | 3.250 | 2.703 | 2.239 | 1.429 |
| Total debt | 1.995 | 2.103 | 3.154 | 2.181 | 3.012 | 3.093 | 2.723 | 2.970 | 3.040 | 3.250 | 2.703 | 2.239 | 1.429 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
27.4%
This company
38.2%
Market median
-28% vs market
20122024
Return on equity
2.5%
This company
18.4%
Market median
-86% vs market
20122024
Net profit margin
10.8%
This company
8.1%
Market median
+33% vs market
20122024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20122024
Debt / equity
2.65×
This company
0.62×
Market median
-327% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PT Management | Management | 2025 | — | — |
JT Founder | Founder | 1993 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
THIBERG HOLDING ApS | Company | 100.0% | 100.0% | 2008 |
NOVACARE ApS | Company | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
THIBERG HOLDING ApS
NOVACARE ApS Board members of NOVACARE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Thiberg | Management | 0 companies |
| Jeanette Thiberg | Founder | 0 companies |